D-1442-2019 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-1442-2019 was initiated by Zydus Pharmaceuticals USA Inc on May 6, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. The recall status is terminated (terminated Sep 16, 2021). Affected quantity: 204 1000-count bottles.

Recall details

Product Type
Drugs
Report Date
Jun 26, 2019
Initiation Date
May 6, 2019
Termination Date
Sep 16, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
204 1000-count bottles

Product description

Pramipexole Dihydrochloride Tablets 0.125 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-10

Reason for recall

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Distribution pattern

Nationwide in the USA

Code information

Lot: M714919, EXP Dec-19, M815081, EXP Aug-20, M900475, EXP Dec-20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1442-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1442-2019. Report a data issue: hello@regdatalab.com.